Black Spider 50 EPH Pharmaceutical

£49.00

Black Spider 50 EPH Pharmaceutical is an ephedra-based thermogenic research compound formulated for in-vitro metabolic studies. Each capsule contains standardised ephedra extract alongside synergistic compounds for laboratory investigation of thermogenesis pathways.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Black Spider 50 EPH Pharmaceutical
Black Spider 50 EPH Pharmaceutical
£49.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

About Black Spider 50 EPH Pharmaceutical

Black Spider 50 EPH Pharmaceutical is an ephedra-based thermogenic research compound designed for in-vitro metabolic pathway investigation. This formulation combines standardised ephedra extract with complementary botanical compounds to create a comprehensive research tool for examining thermogenic mechanisms in laboratory settings. Researchers at Stroid UK Shop utilise this compound to study sympathomimetic pathways and metabolic rate modulation in controlled experimental environments.

The compound represents a standardised approach to ephedra research, providing consistent alkaloid profiles for reproducible experimental outcomes. Unlike traditional SARMs that target androgen receptors, or peptides that modulate growth factors, Black Spider 50 EPH works through adrenergic receptor activation to examine thermogenic responses in research models.

Laboratory Applications

Research applications for Black Spider 50 EPH Pharmaceutical encompass multiple areas of metabolic investigation. Scientists examine its effects on beta-adrenergic receptor stimulation, studying how ephedra alkaloids influence cellular energy expenditure and thermogenesis pathways. The compound serves as a valuable tool for investigating sympathetic nervous system activation in laboratory models.

Researchers analyse the synergistic interactions between ephedra alkaloids and accompanying botanical extracts, evaluating how these combinations affect metabolic enzyme activity and cellular ATP production. Studies focus on examining norepinephrine release mechanisms and their downstream effects on lipolytic pathways in experimental settings. The formulation allows for controlled investigation of thermogenic responses without the complexity of whole-plant extracts.

Comparative studies utilise Black Spider 50 EPH alongside other ephedra extract compounds to evaluate relative potencies and mechanisms of action. Laboratory protocols examine dose-response relationships and temporal effects on metabolic parameters in research models.

Technical Specifications

Black Spider 50 EPH Pharmaceutical Research Specifications
Parameter Specification
Product Name Black Spider 50 EPH Pharmaceutical
Primary Component Standardised Ephedra Extract
Form Capsulated Research Compound
Purity Verify with supplier
Molecular Formula Verify with supplier
Storage Requirements Cool, dry place away from light
Shelf Life 24 months when stored properly
Research Applications Thermogenic pathway studies, adrenergic research

Compliance and Research Use

Black Spider 50 EPH Pharmaceutical is supplied exclusively for in-vitro research applications and laboratory studies. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols and safety measures when handling this material. All studies should be conducted under appropriate ethical oversight and institutional guidelines for research chemical use.

Related